Joo Cheol Shim

Summary

Affiliation: Inje University
Country: Korea

Publications

  1. ncbi Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study
    Do Un Jung
    Department of Psychiatry, Dongseo Hospital, Masan, Republic of Korea
    J Clin Psychiatry 67:1391-6. 2006
  2. pmc Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial
    Joo Cheol Shim
    Department of Psychiatry, College of Medicine, Inje University, Busan, Republic of Korea
    Neuropsychopharmacology 37:660-8. 2012
  3. ncbi Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial
    Joo Cheol Shim
    Clinical Trial Center, Department of Psychiatry and Clinical Pharmacology, Busan Paik Hospital, Inje University, Busan 614 735, Republic of Korea
    Am J Psychiatry 164:1404-10. 2007
  4. ncbi Cortisol response to buspirone in extended abstinent alcoholics
    Young Hoon Kim
    Department of Psychiatry, Busan Paik Hospital 633 165 Gaegum Dong, Busanjin Gu, 614 735, Republic of Korea
    Alcohol Alcohol 39:287-9. 2004
  5. doi Bone mineral density and osteoporosis risk in older patients with schizophrenia
    Do Un Jung
    Department of Psychiatry and Clinical Pharmacology, Busan Paik Hospital, Inje University, Busan, Republic of Korea
    J Clin Psychopharmacol 31:406-10. 2011
  6. ncbi Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia
    Joo Cheol Shim
    Department of Psychiatry, Inje University, Busan, Korea
    J Neuropsychiatry Clin Neurosci 17:221-6. 2005
  7. doi Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report
    Joo Cheol Shim
    J Clin Psychopharmacol 28:353-4. 2008
  8. ncbi The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia
    Do Un Jung
    J Clin Psychopharmacol 25:613-5. 2005
  9. ncbi Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects
    Ji Young Park
    Department of Pharmacology and Pharmacogenetics Research Center, Inje University College of Medicine, Busan, Korea
    J Clin Psychopharmacol 26:135-42. 2006
  10. ncbi Cardiovascular disease in relation to weight in deceased persons with schizophrenia
    Robert R Conley
    Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, 21228, USA
    Compr Psychiatry 46:460-7. 2005

Collaborators

Detail Information

Publications12

  1. ncbi Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study
    Do Un Jung
    Department of Psychiatry, Dongseo Hospital, Masan, Republic of Korea
    J Clin Psychiatry 67:1391-6. 2006
    ..This study investigates bone mineral density (BMD) and the association between BMD and hormonal changes in Korean patients with schizophrenia...
  2. pmc Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial
    Joo Cheol Shim
    Department of Psychiatry, College of Medicine, Inje University, Busan, Republic of Korea
    Neuropsychopharmacology 37:660-8. 2012
    ..In some cases, effects of treatment varied between smokers and non-smokers. Further study is required to assess the functional significance of these changes...
  3. ncbi Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial
    Joo Cheol Shim
    Clinical Trial Center, Department of Psychiatry and Clinical Pharmacology, Busan Paik Hospital, Inje University, Busan 614 735, Republic of Korea
    Am J Psychiatry 164:1404-10. 2007
    ..The authors investigated the effect of adjunctive treatment with aripiprazole on hyperprolactinemia and psychopathology in patients with schizophrenia maintained with haloperidol...
  4. ncbi Cortisol response to buspirone in extended abstinent alcoholics
    Young Hoon Kim
    Department of Psychiatry, Busan Paik Hospital 633 165 Gaegum Dong, Busanjin Gu, 614 735, Republic of Korea
    Alcohol Alcohol 39:287-9. 2004
    ..Our results show that cortisol response to buspirone was significantly decreased in alcoholic patients compared to normal controls, reflecting decreased 5-HT1A receptor sensitivity...
  5. doi Bone mineral density and osteoporosis risk in older patients with schizophrenia
    Do Un Jung
    Department of Psychiatry and Clinical Pharmacology, Busan Paik Hospital, Inje University, Busan, Republic of Korea
    J Clin Psychopharmacol 31:406-10. 2011
    ..People with schizophrenia are at a higher risk for osteoporosis. The authors investigated the prevalence of low bone density and its risk factors in older Korean patients with schizophrenia...
  6. ncbi Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia
    Joo Cheol Shim
    Department of Psychiatry, Inje University, Busan, Korea
    J Neuropsychiatry Clin Neurosci 17:221-6. 2005
    ..This finding suggests that decreased dopamine (D(2)) receptor sensitivity may result in lower risk of developing TD and may lead to a fuller understanding of the variable expression of D(2)-receptor mediated side effects...
  7. doi Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report
    Joo Cheol Shim
    J Clin Psychopharmacol 28:353-4. 2008
  8. ncbi The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia
    Do Un Jung
    J Clin Psychopharmacol 25:613-5. 2005
  9. ncbi Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects
    Ji Young Park
    Department of Pharmacology and Pharmacogenetics Research Center, Inje University College of Medicine, Busan, Korea
    J Clin Psychopharmacol 26:135-42. 2006
    ..The moderate effect of CYP2D6*10 genotype on the pharmacokinetics and pharmacodynamics of haloperidol seems to be augmented by the presence of itraconazole pretreatment...
  10. ncbi Cardiovascular disease in relation to weight in deceased persons with schizophrenia
    Robert R Conley
    Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, 21228, USA
    Compr Psychiatry 46:460-7. 2005
    ....
  11. ncbi Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death
    Deanna L Kelly
    Maryland Psychiatric Research Center, University of Maryland, Baltimore, MD 21228, USA
    J Psychiatr Res 38:531-6. 2004
    ..Individuals who die by suicide experience higher rates of depressive symptoms, suicidal thoughts and positive symptoms during their life...
  12. ncbi Fluoxetine augmentation of haloperidol in chronic schizophrenia
    Joo Cheol Shim
    J Clin Psychopharmacol 23:520-2. 2003